Skip to main content
. 2013 Oct 7;24(11):2916–2922. doi: 10.1093/annonc/mdt374

Figure 1.

Figure 1.

Progression-free survival of the entire cohort of patients (A), and according to performance status (PS) (B), number of metastatic sites (C) and type of chemotherapy regimen (D).